M.J. Requena

1.6k total citations
48 papers, 1.1k citations indexed

About

M.J. Requena is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, M.J. Requena has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 14 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in M.J. Requena's work include Urinary and Genital Oncology Studies (16 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (10 papers). M.J. Requena is often cited by papers focused on Urinary and Genital Oncology Studies (16 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Chronic Lymphocytic Leukemia Research (10 papers). M.J. Requena collaborates with scholars based in Spain, United States and Italy. M.J. Requena's co-authors include Rodolfo Montironi, Antonio López-Beltrán, Rafael J. Luque, Jose Alvarez‐Kindelán, Liang Cheng, Ana Blanca, Enrique Gómez‐Gómez, Ricardo González‐Cámpora, Julia Carrasco‐Valiente and Domenico Franco Merlo and has published in prestigious journals such as Blood, Scientific Reports and The FASEB Journal.

In The Last Decade

M.J. Requena

45 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Requena Spain 18 567 274 261 179 166 48 1.1k
Shiu-Feng Huang Taiwan 20 431 0.8× 241 0.9× 339 1.3× 292 1.6× 89 0.5× 42 1.1k
Raffaella Santi Italy 18 328 0.6× 201 0.7× 245 0.9× 359 2.0× 104 0.6× 94 1.3k
Fernando Augusto Soares Brazil 16 159 0.3× 248 0.9× 213 0.8× 98 0.5× 126 0.8× 71 723
Yosuke Morizawa Japan 16 571 1.0× 295 1.1× 416 1.6× 382 2.1× 34 0.2× 143 1.3k
Takako Yoshioka Japan 16 293 0.5× 325 1.2× 260 1.0× 241 1.3× 86 0.5× 126 1.0k
Piero De Carli Italy 15 399 0.7× 221 0.8× 135 0.5× 209 1.2× 30 0.2× 34 821
Say‐June Kim South Korea 19 687 1.2× 286 1.0× 250 1.0× 190 1.1× 39 0.2× 79 1.2k
Kiyohiko Hotta Japan 19 256 0.5× 288 1.1× 327 1.3× 166 0.9× 53 0.3× 88 1.1k
Hajime Takayasu Japan 18 765 1.3× 650 2.4× 212 0.8× 493 2.8× 69 0.4× 63 1.6k
Roman Metzger Germany 18 316 0.6× 252 0.9× 68 0.3× 130 0.7× 25 0.2× 58 870

Countries citing papers authored by M.J. Requena

Since Specialization
Citations

This map shows the geographic impact of M.J. Requena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Requena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Requena more than expected).

Fields of papers citing papers by M.J. Requena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Requena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Requena. The network helps show where M.J. Requena may publish in the future.

Co-authorship network of co-authors of M.J. Requena

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Requena. A scholar is included among the top collaborators of M.J. Requena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Requena. M.J. Requena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lozano, Juan José, Mercedes Ingelmo‐Torres, Montserrat Domènech, et al.. (2025). Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines. 13(3). 740–740.
2.
Araujo, Jhajaira M., Alejandro Alfaro, Williams Fajardo, et al.. (2024). Socioeconomic disparities and the genomic landscape of gastric cancer. Scientific Reports. 14(1). 15070–15070. 1 indexed citations
3.
Gaya, Josep María, Solomon L. Woldu, Paolo Verri, et al.. (2022). Incidental diagnosis of bladder cancer in a national observational study in spain. Actas Urológicas Españolas (English Edition). 47(5). 296–302. 1 indexed citations
4.
Gómez‐Gómez, Enrique, et al.. (2020). Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance. Korean Journal of Radiology. 22(4). 559–559. 4 indexed citations
5.
Hormaechea‐Agulla, Daniel, Manuel D. Gahete, Juan M. Jiménez‐Vacas, et al.. (2017). The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Molecular Cancer. 16(1). 146–146. 38 indexed citations
6.
Cózar, J.M., B. Miñana, J. Palou-Redorta, et al.. (2014). Análisis comparativo de la incidencia de cáncer de vejiga en las comunidades de Andalucía, Cataluña y Comunidad de Madrid en el año 2011. Actas Urológicas Españolas. 39(7). 420–428. 2 indexed citations
7.
López, J.C. Regueiro, et al.. (2012). Opciones de tratamiento quirúrgico en la estenosis de uretra bulbar. Actas Urológicas Españolas. 37(3). 167–173. 6 indexed citations
8.
Martı́n, Alejandro, E. Condé, Montserrat Arnán, et al.. (2008). R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. Haematologica. 93(12). 1829–1836. 134 indexed citations
9.
Baena-Cañada, José Manuel, et al.. (2008). Efecto de la quimioterapia neoadyuvante con antraciclinas en la angiogenia del cáncer de mama. Medicina Clínica. 130(19). 721–725. 2 indexed citations
10.
Agüera, M.L., María Dolores Navarro, Alberto Rodríguez‐Benot, et al.. (2007). Simultaneous pancreas-kidney transplant: a single-center long-term outcome. Journal of Nephrology. 20(2). 173–176. 9 indexed citations
11.
López-Beltrán, Antonio, M.J. Requena, Liang Cheng, & Rodolfo Montironi. (2007). Pathological variants of invasive bladder cancer according to their suggested clinical significance. British Journal of Urology. 101(3). 275–281. 40 indexed citations
12.
González‐Cámpora, Ricardo, Rafael J. Luque, Jose Alvarez‐Kindelán, et al.. (2006). Apoptotic and proliferation indexes in primary superficial bladder tumors. Cancer Letters. 242(2). 266–272. 15 indexed citations
13.
López-Beltrán, Antonio, et al.. (2006). Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. Journal of Clinical Pathology. 60(3). 332–335. 50 indexed citations
14.
Quintero, Ana, Jose Alvarez‐Kindelán, Rafael J. Luque, et al.. (2006). Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. Journal of Clinical Pathology. 59(1). 83–88. 76 indexed citations
15.
Luque, Rafael J., et al.. (2005). Association of human herpesvirus type 6 DNA with human bladder cancer. Cancer Letters. 230(1). 20–24. 10 indexed citations
16.
López-Beltrán, Antonio, et al.. (2003). Hepatoid adenocarcinoma of the urinary bladder. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 442(4). 381–387. 49 indexed citations
17.
López-Beltrán, Antonio, Rafael J. Luque, Jose Alvarez‐Kindelán, et al.. (2003). Prognostic Factors in Stage T1 Grade 3 Bladder Cancer Survival: The Role of G1–S Modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and Proliferation Index (ki67-MIB1). European Urology. 45(5). 606–612. 96 indexed citations
18.
Steegmann, Juan Luis, et al.. (1998). Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response. American Journal of Hematology. 59(1). 95–97. 10 indexed citations
19.
20.
Elvira, J.M. Llamas, et al.. (1989). 99Tcm-MAG3 for quantitation of differential renal function. Nuclear Medicine Communications. 10(10). 759–764. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiu-Feng Huang Breakdown of academic impact, for papers by Raffaella Santi Breakdown of academic impact, for papers by Fernando Augusto Soares Breakdown of academic impact, for papers by Yosuke Morizawa Breakdown of academic impact, for papers by Takako Yoshioka Breakdown of academic impact, for papers by Piero De Carli Breakdown of academic impact, for papers by Say‐June Kim Breakdown of academic impact, for papers by Kiyohiko Hotta Breakdown of academic impact, for papers by Hajime Takayasu Breakdown of academic impact, for papers by Roman Metzger
Rankless by CCL
2026